Dosing strategies and time course of response to antimanic drugs

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 13, 1996, Pages 4-9

  Bowden, Charles L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

ADULT; ASTHENIA; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FEVER; HUMAN; MANIA; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; VOMITING;

BIPOLAR DISORDER; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0030454868     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. Arch Gen Psychiatry 1993;54:405-418
2. Stokes PE, Shamoian CA, Stoll PM, et al. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971;1:1319-1325
3. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
4. Bowden CL. Predictors of response to divalproex and lithium. J Clin Psychiatry 1995;56(suppl 3):25-30
5. Swann AC, Secunda SK, Koslow SH, et al. Mania: sympathoadrenal function and clinical state. Psychiatry Res 1991;37:195-205
6. Keller MB, Lavori PW, Coryell W, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986;255:3138-3142
7. Grof P, Alda M, Grof E, et al. The challenge of predicting response to stabilising lithium treatment: the importance of patient selection. Br J Psychiatry 1993;163(suppl 21):16-19
8. Swann AC, Secunda SK, Katz MM, et al. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res 1986;18:127-141
9. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder. Am J Psychiatry 1995;152:379-384
10. Rey AC, Jimerson DC, Post RM. Lithium and electrolytes in cerebrospinal fluid of affectively ill patients during acute and chronic lithium treatment. Communications in Psychopharmacology 1979;3:267-278
11. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
12. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988
13. Stokes PE, Kocsis JH, Arcuni OJ. Relationship of lithium chloride dose to treatment response in acute mania. Arch Gen Psychiatry 1976;33: 1080-1084
14. Goodwin FK, Murphy DL, Bunney WE Jr. Lithium carbonate treatment in depression and mania: a longitudinal double-blind study. Arch Gen Psychiatry 1969;21:486-496
15. Baldessarini RJ, Tondo L, Suppes T, et al. Pharmacological treatment of bipolar disorder throughout the life-cycle. In: Shulman K, Tohen M, Kutcher SP, eds. Mood Disorders Throughout the Life-Span. New York, NY: John Wiley & Sons; 1996
16. Miller AL, Bowden CL, Plewes J. Lithium and impairment of renal concentrating ability. J Affect Disord 1985;9:115-119
17. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995;56(suppl 3):19-24
18. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord 1988;15:9-15
19. Freeman TW, Clothier JL, Pazzaglia P, et al. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-111
20. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990;147: 431-434
21. Primeau F, Fontaine R, Beauclair L. Valproic acid and panic disorder. Can J Psychiatry 1990;35:248-250
22. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994;44(suppl 7):S17-S22
23. Popper CW. Balancing knowledge and judgment: a clinician looks at new developments in child and adolescent psychopharmacology. Pediatric Psychopharmacology II 1995;4(2):483-510
24. Bowden CL, Janicak PG, Orsulak P, et al. Relationship of serum valproate concentration to response in mania. Am J Psychiatry 1996;153: 765-770
25. Pope HG Jr, McElroy SL, Keck PE Jr, et al. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48: 62-68
26. Delgado MR. Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 1994;9:311-314
27. Pedersen B, JuulJensen P. Electroencephalographic alterations during intoxication with sodium valproate: a case report. Epilepsia 1984;25: 121-124
28. Bowden CL, Orsulak P, Swann A, et al. Relationship of free and total serum valproate in treatment of mania [abstract]. Presented at the 34th annual meeting of the American College of Neuropsychopharmacology; December 11-14, 1995; San Juan, Puerto Rico
29. Papatheodorou G, Kutcher SP, Katic M, et al. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults. J Clin Psychopharmacol 1995;15:110-116
30. McFarland BH, Miller MR, Straumfjord AA. Valproate use in the older manic patient. J Clin Psychiatry 1990;51:479-481
31. Wilder BJ, Karas BJ, Penry JK, et al. Gastrointestinal tolerance of divalproex sodium. Neurology 1983;33:808-811
32. Jacobsen FM. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 1993;54:229-234
33. Weisler RH, Risner ME, Ascher JA, et al. Use of lamotrigine in the treatment of bipolar disorder [abstract]. In: New Research Program and Abstracts of the 147th Annual Meeting of the American Psychiatric Association; May 26, 1994; Philadelphia, Pa. Abstract NR611:216
34. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986;22:613-620
35. Okuma T, Yamashita I, Takahashi R, et al. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 1990;23:143-150
36. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992;86:38-41
37. Emrich HM, Wolf R. Valproate treatment of mania. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:691-701
38. Sharma V, Persad E, Mazmanian D, et al. Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can J Psychiatry 1993;38:137-139
39. Ketter TA, Pazzaglia P, Post RM. Synergy of carbamazepine and valproic acid in affective illness: case report and review of literature. J Clin Psychopharmacol 1992;12:276-282
40. Lambert PA, Venaud G. Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders. Nervure Journal de Psychiatrie 1995;7:1-9
41. Vahip S, Ozkan B, Ayan A, et al. Elevation of plasma lithium at the end of mania and some biochemical correlates [abstract]. Presented at the 2nd International Conference on New Directions in Affective Disorders; September 3-8, 1995; Jerusalem, Israel. Abstract P31
42. Citrome L. The use of lithium, carbamazepine, and valproic acid in a state operated psychiatric hospital. J Pharmacy Technology 1995;11:55-59
43. Wehr TA, Sack DA, Rosenthal NE. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987;144:201-204
44. Bowden CL. Treatment of bipolar disorder. In: Schalzberg A, Nemeroff C, cds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995:603-614